2-Amino-5-bromo-3-(hydroxymethyl)pyridine: An In-Depth Look From the Production Floor

For years, our team has focused on producing specialized pyridine derivatives, and 2-Amino-5-bromo-3-(hydroxymethyl)pyridine—often referred to by its CAS number 351005-46-6—stands out for several reasons. Our experience with this molecule has shown that it provides a unique intersection of chemical stability and reactivity. The compound’s structure—a bromine at position 5, an amino group at position 2, and a hydroxymethyl at position 3—offers distinct advantages for researchers and manufacturers looking to build complex molecules with precision. Production for this compound takes time and care, something we’ve learned is absolutely necessary for purity and reliability.

Chemical Profile: Working With This Pyridine Derivative

In our manufacturing facility, we don’t deal with theory. Every batch of 2-Amino-5-bromo-3-(hydroxymethyl)pyridine starts with thoroughly vetted raw materials. We use modern purification techniques to achieve high purity, regularly exceeding 98% by HPLC. Over time, we’ve found that strict control of temperature and humidity during handling makes a real difference in product stability. Fail to minimize exposure to moisture or sunlight, and you can jeopardize the entire batch—a lesson we’ve learned on the shop floor.

The compound’s physical form is a pale to off-white crystalline powder. This is a direct result of our controlled crystallization processes. Deviations in temperature during crystallization tend to cause discoloration or clumping—clear visual flags that help our technicians catch inconsistencies early on. The substance’s molecular formula—C6H7BrN2O—gives it a molar mass close to 203 grams per mole, and that mass means anyone scaling up a reaction must pay attention to stoichiometry, not just ‘scale up and hope for the best.’

Anyone who’s spent time in a wet chemistry lab will notice the compound’s slight solubility in water and moderate solubility in organic solvents such as methanol and DMF. This plays a big role in formulation and downstream synthesis; solvents with too much water content risk partial hydrolysis of the hydroxymethyl group, something we watch out for during both bulk production and sampling.

Applications: Practical Insights and User Feedback

We’ve watched this compound gain steady traction among pharmaceutical chemists, mostly as a key intermediate in a handful of small molecule syntheses. The bromine atom at the 5-position isn’t there for decoration. That bromine gives synthetic chemists a nice handle for Suzuki, Buchwald-Hartwig, or Heck cross-coupling reactions. Several teams have updated us about modifications they’ve made using this scaffold when building substituted heterocyclic drugs—especially kinase inhibitors and small molecule therapeutics.

From an agrochemical perspective, this derivative presents a valuable starting point for assembling bioactive compounds targeting fungi and insect pests. When we first started offering this substance, the requests often centered around research-scale projects. Lately, as our customers have moved programs out of discovery and into pilot production, we’ve been producing multi-kilogram lots. Robust scale-up isn’t something pulled off with a snap of the fingers—it requires calibration of industrial glassware, tight process control, and constant real-time monitoring of reaction endpoints.

Compared to more common pyridine derivatives—such as 2-amino-5-bromopyridine or 3-hydroxymethylpyridine—adding both the amino group and the hydroxymethyl doesn’t just change the physical properties but also the way the molecule enters subsequent reactions. Our chemists have run side-by-side comparisons in model transformations; we often observe that the dual presence of nitrogen and the hydroxymethyl backbone opens new doors in nucleophilic substitution and reductive amination. We’ve also documented better yields under certain conditions—especially in reactions forming carbon-nitrogen bonds—when using this bromo-hydroxymethyl starting point.

Specifying the Right Product: Real-World Differences

Customers in process R&D departments often ask why they should select this molecule over a simpler analog. We approach this by considering reactivity patterns, ease of purification, and metabolic stability of the next desired product. Adding a hydroxymethyl side chain, for example, increases the molecule’s hydrophilicity. In some programs, this helps downstream separation; in others, it creates a need for more careful process validation. The presence of both amino and bromine groups gives greater flexibility for multi-step routes—especially for those chasing functionalized pyridines, which form core pieces of kinase inhibitors, antivirals, and enzyme blocking agents.

Our job as a manufacturer goes beyond just making the batch. We document and investigate subtle differences between isomeric and positional analogs—customers don’t want to discover surprises on the kilo scale. Through experience, we’ve found that the extra hydroxymethyl at position 3 not only enhances water solubility but also can influence hydrogen bonding patterns in final drug candidates. Several collaborations with medicinal chemists have proven how changing one group affects both in vitro and in vivo results. This isn’t speculation; it’s a result of running hundreds of reactions, mapping purification yields, and seeing how impurities appear under various conditions.

Purity, Handling, and Shelf Life: Lessons From the Floor

Working with thousands of samples, we pay a lot of attention to how this compound ages. It’s a solid with moderate shelf life if kept sealed, dry, and shielded from light. Once the product absorbs moisture, clumping and accelerated degradation start to show up fast, especially in uncontrolled warehouses. Over time, we’ve improved our packaging based on actual user feedback—switching to high-barrier lamination for bulk containers and single-use liners for research samples. These simple steps make a difference when customers store material for long-term projects.

Purity after synthesis and purification stays high if handled with nitrile gloves and transferred in a low-humidity glovebox. We’ve done our own side-by-side purity assays after six and twelve months’ storage; batches left in open dishes, even for a few hours, pick up measurable impurities. That kind of contamination—whether from the atmosphere or cross-contact during transfer—can impact both biological and chemical performance in sensitive reactions.

Shipping is another area where small decisions matter. We limit temperature variations and add desiccants. On long overseas shipments, even minor lapses in packaging integrity create unwanted side products or discoloration. Nothing frustrates us more than seeing pristine batches compromised by avoidable shipping mistakes.

Supporting Innovation: Collaboration Over Commoditization

We’ve watched too many promising projects stall because someone settled for a generic, off-spec or foreign-sourced intermediate. For new chemical entities destined for regulatory review or market launch, traceability and reproducibility mean everything. Our records for every batch include not just basic lot numbers but also analytic readouts, impurity profiles, and detailed process notes that capture changes in plant parameters. This kind of data trail has saved several clients headaches when regulatory authorities requested supporting technical documents years later.

We view our role not as a faceless supplier, but as a constructive partner. Periodically, customers send us challenging feedback: a reaction didn’t go as planned, or a product from another vendor exhibited unexpected background peaks. We take these conversations seriously—by reproducing their chemistry, sending out samples from different synthesis runs, and even assisting in troubleshooting complex purifications. This close loop between production chemists and end users means fewer surprises down the road and often faster route optimization.

What Sets This Molecule Apart in Practice?

Chemical differences between pyridine derivatives aren’t just trivia for the periodic table. Swapping out one substituent can turn a synthesis from tedious into one that runs clean and at scale. Our production records show that 2-Amino-5-bromo-3-(hydroxymethyl)pyridine gives sharper, more controllable reactions than many related compounds. The amino group boosts nucleophilicity, while the bromine sets up useful cross-coupling. The extra hydroxymethyl group has allowed customers to graft on alcohol, aldehyde, or amine groups without lengthy intermediate steps.

Over the years, we’ve watched some end users start with our product and build entirely new synthetic strategies around it. For example, process chemists using this compound as a core scaffold for a patent-protected therapeutic achieved a significant reduction in overall synthetic steps. Others working in crop science took advantage of the oxidative stability offered by the amino and bromine combination, reporting higher activity in biological screens. These stories, shared in conference calls and technical exchanges, help our operators and process engineers rethink and improve our own manufacturing routes.

Addressing Scale-Up and Process Safety Challenges

Scaling up this compound is no trivial exercise. During our first multi-kilo campaign, we encountered a stubborn byproduct during the ammonolysis step that we hadn’t seen at small scale. Instead of rushing, we paused, reran smaller batches, and mapped the influence of agitation, solvent ratio, and temperature gradient. Eventually, that careful hands-on work paid off—yield stepped up and the purity climbed back above 99%. These are the kinds of lessons you just don’t get from machine or automated process simulation.

Safety can’t take a back seat. We always monitor for volatiles during reaction and work-up—there’s a faint odor at elevated temperatures, but our containment and ventilation systems limit airborne release. PPE and process controls help keep trace brominated fumes out of the workspace. Over several production cycles, our team noticed small improvements in blending and load-in techniques, cutting down both exposure risk and batch-to-batch variation. These tweaks were prompted not by theory, but by listening to operators and noting small but real differences in their daily workflow.

Regulatory and Analytical Requirements: Avoiding Setbacks

Pharma and agrochemical companies often demand a strict impurity profile. Over the years, we’ve moved toward more detailed routine analysis on LC-MS and NMR—not just for our own QA, but to provide the documentation our clients require for filings. In some cases, an unexpected impurity below 0.1% triggered a long investigation into a process additive. We treat those reports not as nuisances, but as necessary parts of ensuring the user's success further down the pipeline.

Providing a reliable Certificate of Analysis comes from years of standardizing our methods: the calibration curve for each major impurity, split batches for stability testing, keeping exact records for every column and reagent lot. We’ve seen the benefit of this discipline: clients resolve technical questions with regulators faster, and we see fewer repeat issues with downstream product performance.

For large-volume clients, missing a spec isn’t just a minor hiccup—it can cause whole programs to pause. Our team conducts intermediate checks and even ships backup samples during extended production runs to avoid surprises. Our staff are on hand to provide live updates if a client’s regulatory team finds a discrepancy, reducing downtime and stress for all involved.

Ongoing Challenges and What We’re Doing Next

Making this compound at ever-higher volumes, we still run into new questions. How do tweaks to reaction sequence or purification steps impact trace-metal content? Can we keep boron and iron below user-mandated levels? Typical requests now include higher standards for residual solvents, so we continuously invest in new GC-FID calibration standards. It’s never enough just to clear the previous benchmark.

Supply chains keep shifting. Last year, sourcing one particular precursor turned unpredictable. Our team tackled this by bulk-ordering trusted lots and qualifying two alternate suppliers. We actively manage backup stocks—a lesson hard learned after one co-supplier failed to deliver on time, almost disrupting a client’s major scale-up. That risk mitigation gives us confidence to promise tighter delivery timelines.

Why The Source Matters

Making a specialty chemical like 2-Amino-5-bromo-3-(hydroxymethyl)pyridine at scale is much more than mixing a few reagents. Day-to-day decisions—how carefully staff measure out a catalyst, pre-wash the glassware, or respond to a shift in humidity—can mark the line between a successful batch and unusable off-specification material. Our equipment investment isn’t just for show. Real-time QCL monitoring, flask-by-flask in-process checks, and post-synthesis chromatography keep the finished product aligned with the documented requirements.

Every manufacturer says their product is reliable. Our approach relies on the institutional memory of process operators, continuous scrutiny of process variables, and steady conversation with users ranging from lab chemists to plant managers. We know how much rides on a single intermediate—especially when the project’s viability or a patent deadline depends on consistent, high-purity material arriving when promised.

For those looking to move from pilot lab to commercial production, choosing a reliable source for 2-Amino-5-bromo-3-(hydroxymethyl)pyridine makes a difference in both the chemistry and business outcome. Lessons learned from thousands of batches, real-world feedback, and continuous process refinement underscore how quality doesn’t happen by accident—it comes from deliberate, sometimes painstaking effort at every step.